Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Onasemnogene abeparvovec-xioi
Medication labelZOLGENSMA is an adeno-associated virus (AAV) vector-based gene therapy indicated for the treatment of pediatric patients less than 2 years…
Why this: Advisory · dailymed-prescription
ZOLGENSMA is an adeno-associated virus (AAV) vector-based gene therapy indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene. Limitations of Use The safety and effectiveness of repeat administration of ZOLGENSMA have not been evaluated [see Adverse Reactions (6.2)]. The use of ZOLGENSMA in patients with advanced SMA (e.g., complete paralysis of limbs, permanent ventilator-dependence) has not been evaluated [see Clinical Studies (14)].
- generic_name
- onasemnogene abeparvovec-xioi
- brand_name
- isopropyl alcohol
- product_names
- onasemnogene abeparvovec-xioi, isopropyl alcohol
- ndc
- 71894-120, 71894-120-02, 71894-115, 71894-115-01, 71894-121, 71894-121-03, 71894-110, 71894-110-01, 71894-122, 71894-122-03, 71894-123, 71894-123-03, 71894-124, 71894-124-04, 71894-125, 71894-125-04, 71894-126, 71894-126-04, 71894-127, 71894-127-05, 71894-128, 71894-128-05, 71894-129, 71894-129-05, 71894-130, 71894-130-06, 71894-131, 71894-131-06, 71894-132, 71894-132-06, 71894-133, 71894-133-07, 71894-134, 71894-134-07, 71894-135, 71894-135-07, 71894-136, 71894-136-08, 71894-137, 71894-137-08, 71894-138, 71894-138-08, 71894-139, 71894-139-09, 71894-140, 71894-140-09, 71894-141, 71894-141-09, 71894-142, 71894-142-10, 71894-143, 71894-143-10, 71894-144, 71894-144-10, 71894-145, 71894-145-11, 71894-146, 71894-146-11, 71894-147, 71894-147-11, 71894-148, 71894-148-12, 71894-149, 71894-149-12, 71894-150, 71894-150-12, 71894-151, 71894-151-13, 71894-152, 71894-152-13, 71894-153, 71894-153-13, 71894-154, 71894-154-14, 71894-155, 71894-155-14, 71894-156, 71894-156-14
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en